← Eichor
Condition: Genetic Eye Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Genetic Eye Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
NA · 1 location(s) · Sun Yat-sen University · NCT06588764Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00001456Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Sy
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05927688SUCCESS Score Validation in Fuchs Dystrophy
Phase N/A · 1 location(s) · Instituto Ramón y Cajal de Investigación Sanitaria · NCT07265388Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · 18 location(s) · Jaeb Center for Health Research · NCT06837181Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
Phase 3 · 1 location(s) · Minghui Pharmaceutical (Hangzhou) Ltd · NCT07262476InsightRP2 Registry
Phase N/A · 1 location(s) · University of Göttingen · NCT06982417Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Phase N/A · 1 location(s) · Vastra Gotaland Region · NCT05678374Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417Shanghai High Myopia Study
Phase N/A · 1 location(s) · Shanghai High Myopia Study Group · NCT03062085Clinical Trial Readiness for the Dystroglycanopathies
Phase N/A · 1 location(s) · Katherine Mathews · NCT00313677Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degener
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT06375239HYPER MIND - Hyperoxia Effects on Cerebral Hemodynamics
NA · 1 location(s) · Erasme University Hospital · NCT07377162A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Phase 3 · 7 location(s) · Amgen · NCT05767047Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmop
Phase N/A · 1 location(s) · Shanghai Changzheng Hospital · NCT07381413Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease
NA · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT07400757A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
Phase N/A · 1 location(s) · Krystal Biotech, Inc. · NCT06563414Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
Phase 1 · 1 location(s) · Singapore Eye Research Institute · NCT04319848OCT in Diagnosis of Irregular Corneas
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT03504800Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)
Phase 3 · 1 location(s) · Janjira Petsuksiri · NCT06392906An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease
EARLY_Phase 1 · 1 location(s) · HuidaGene Therapeutics Co., Ltd. · NCT07063251Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy
Phase 4 · 1 location(s) · Marian Macsai, MD · NCT03249337Genetic Studies of Strabismus, Nystagmus, and Associated Disorders
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT04770519Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
EARLY_Phase 1 · 2 location(s) · University of Pennsylvania · NCT06932809Genetics of Inherited Eye Disease
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT02471287Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
Phase N/A · 1 location(s) · Shanghai Changzheng Hospital · NCT06590220A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Phase 3 · 11 location(s) · Rhythm Pharmaceuticals, Inc. · NCT06760546Microsurgical Robot-assisted Corneal Transplant
NA · 1 location(s) · CHU de Reims · NCT06844123A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
Phase 3 · 27 location(s) · Zai Lab (Shanghai) Co., Ltd. · NCT07211776Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
Phase 2/Phase 3 · 2 location(s) · Sling Therapeutics, Inc. · NCT06112340
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.